CDC recommends new omicron-targeting COVID-19 boosters for ages 12 and older
On Sept. 1, 2022, the Centers for Disease Control and Prevention (CDC) recommended people ages 12 and older receive the new, reformulated COVID-19 vaccine as a booster to target the omicron variant of the virus.
People ages 12 to 17 may receive the Pfizer booster. Those ages 18 and older may choose between Pfizer or Moderna. People can get the new booster at least two months after their primary series or their last booster dose. The new formulation should be widely available at your pharmacy or doctor’s office.
Federal government to stop buying COVID-19 vaccines, treatments, tests
This means providers such as pharmacies, doctor’s offices and hospitals will begin buying COVID-19 products directly from manufacturers. This transition will occur over time and is expected to conclude mid-2023.
For example, the monoclonal antibody treatment called bebtelovimab was already transitioned from being purchased and subsidized by the federal government to the private market in August. The COVID-19 vaccine is expected to shift to provider purchasing in early 2023. The treatment Paxlovid could shift in mid-2023.
At-home tests have been readily available in pharmacies and supermarkets but are no longer available for free from the federal government.
We anticipate as products move to commercial purchasing coverage would be applied according to an individual’s health plan benefits.
We’re here to help
The disease-prevention benefits of vaccines are much greater than the possible side effects for most people. More information about the available COVID-19 vaccines, including booster shots, is available on the CDC website. Visit your state’s health department website or the CDC’s Vaccine Finder site to find out where all eligible people can get a COVID-19 vaccine:
More information about your coverage for COVID-19 vaccinations, testing and treatment can be found at regence.com.